Skip to content

The post operative analgesic effect of gabapentine in patients undergoing abdominal hysterectomy.

The post operative analgesic effect of gabapentine in patients undergoing abdominal hysterectomy.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903112967N2
Enrollment
50
Registered
2010-06-01
Start date
2010-05-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post abdominal hysterectomy pain. Postprocedural disorder of genitourinary system, unspecified

Interventions

Intervention 1: Gabapentine, 1200mg orally one hour before operation. Intervention 2: Placebo, 1200mg orally simillar to gabapentin exception for effective material one hour before operation.
Treatment - Drugs
Gabapentine, 1200mg orally one hour before operation
Placebo, 1200mg orally simillar to gabapentin exception for effective material one hour before operation

Sponsors

Vice-chancelor for Research, Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 35-50 years, candidate for hysterectomy Exclusion criteria: Allergy to morphine or gabapentine, chronic use of analgesic drugs or steroid, drug addiction, history of cardiovascular, hepatic, respiratory, or renal diseases, presence of asthma or chronic pain syndrome

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post-abdominal hysterectomy pain. Timepoint: 2, 6, 12, 24 hours after operation. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Morphine consumption. Timepoint: 2, 6, 12, 24 hours after operation. Method of measurement: Number of morphine ampules consumption.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fatemeh Foroozanfard

Kashan University of Medical Sciences

forozanfar_f@kaums.ac.irfatemehforoozanfard@yahoo.com+98 36 1542 1355

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026